Begin main content

Buprenorphine Formulations for the Treatment of Opioid Use Disorders: Comparative Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Last updated: April 2, 2018
Project Number: RA0951-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Reference List
Result type: Report

Question

  1. What is the comparative clinical effectiveness of various buprenorphine or buprenorphine/naloxone formulations for the treatment of opioid use disorders?
  2. What is the cost-effectiveness of various buprenorphine or buprenorphine/naloxone formulations for the treatment of opioid use disorders?
  3. What are the evidence-based guidelines regarding the use of various buprenorphine or buprenorphine/naloxone formulations for the treatment of opioid use disorders?

Key Message

One economic evaluation and two evidence-based guidelines were identified on the use of various buprenorphine or buprenorphine/naloxone formulations for the treatment of opioid use disorders.